市場調査レポート

商品コード

1522738

持続血糖モニタリングの世界市場の評価：コンポーネント別、年齢層別、糖尿病タイプ別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Continuous Glucose Monitoring Market Assessment, By Component, By Age Group, By Diabetes Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年07月30日
発行: Market Xcel - Markets and Data
ページ情報: 英文 233 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,500 646,065円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 818,349円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,177,274円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の持続血糖モニタリング（CGM）の市場規模は、予測期間の2024年～2031年に11.13％のCAGRで拡大し、2031年にかけて成長すると予測されています。持続血糖モニタリング市場は、医療機器産業の不可欠な部分であり、最も速い成長率の1つを占めています。糖尿病有病率の増加、CGMデバイスの採用拡大、糖尿病モニタリングに対する意識の高まり、技術の進歩などが市場を牽引しています。

持続血糖モニタリングデバイスは、グルコースレベルの測定を使用して、フィンガースティック検査を最小限に抑えることで糖尿病を管理します。持続グルコースレベルは、患者の皮膚の上または下にあるセンサーによって一日中測定されます。トランスミッターは、例えばスマートウォッチのようなウェアラブル機器と併用することで、任意の時点における血糖値の変化を表示することができます。とはいえ、糖尿病管理のためにCGMを使用するのは、プロセスを簡略化するもの、慣れるまでに時間がかかります。CGMのデータを利用する場合、タイム・イン・レンジ法では、患者が望ましいグルコースレベルの範囲内にいる期間に加え、グルコースが正常レベルを上回ったり（高血糖）、下回ったり（低血糖）した回数を測定します。血糖測定器は、その人の血糖値の一点推定値を提供するが、CGM装置は、グルコースに関するパターンについてより広い視野を提供します。CGMデバイスは、ユーザーがグルコースレベルを一定の範囲に保ち、グルコースレベルが低い場合と高い場合をなくし、糖尿病に関連する問題を引き起こす可能性を減らすのに役立つことが、いくつかの研究で実証されています。とはいえ、CGMの使用は長期的な解決策です。

CGMの需要は、糖尿病患者の数とともに大幅に増加しています。2,300万人の糖尿病患者のうち31%がインスリン治療を受けているため、継続的血糖モニタリング（CGM）を使用することができます。米国糖尿病学会は、CGMを1型糖尿病患者の治療のゴールドスタンダードとして推奨しており、インスリン治療を受けている2型糖尿病患者にとっては重要な装置です。結論として、糖尿病患者の増加により、持続的血糖モニタリング装置の需要が高まっており、これによりグルコースコントロールが大幅に改善され、糖尿病患者の健康状態が改善される可能性があります。糖尿病患者の増加に伴い、この技術へのアクセスが優先事項となってきています。

当レポートでは、世界の持続血糖モニタリング市場について調査し、市場の概要とともに、コンポーネント別、年齢層別、糖尿病タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 3. Global Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 4. Global Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 5. Global Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 6. Global Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 7. Global Continuous Glucose Monitoring Market Share (%), By Region, 2017-2031F
Figure 8. North America Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 9. North America Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 10. North America Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 11. North America Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 12. North America Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 13. North America Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 14. North America Continuous Glucose Monitoring Market Share (%), By Country, 2017-2031F
Figure 15. United States Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 16. United States Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 17. United States Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 18. United States Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 19. United States Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 20. United States Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 21. Canada Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 22. Canada Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 23. Canada Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 24. Canada Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 25. Canada Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 26. Canada Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 27. Mexico Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 28. Mexico Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 29. Mexico Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 30. Mexico Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 31. Mexico Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 32. Mexico Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 34. Europe Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 35. Europe Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 36. Europe Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 37. Europe Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 38. Europe Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 39. Europe Continuous Glucose Monitoring Market Share (%), By Country, 2017-2031F
Figure 40. Germany Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 41. Germany Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 42. Germany Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 43. Germany Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 44. Germany Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 45. Germany Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 46. France Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 47. France Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 48. France Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 49. France Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 50. France Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 51. France Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 52. Italy Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 53. Italy Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 54. Italy Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 55. Italy Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 56. Italy Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 57. Italy Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 58. United Kingdom Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 59. United Kingdom Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 60. United Kingdom Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 61. United Kingdom Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 62. United Kingdom Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 63. United Kingdom Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 64. Russia Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 65. Russia Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 66. Russia Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 67. Russia Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 68. Russia Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 69. Russia Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 70. Netherlands Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 71. Netherlands Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 72. Netherlands Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 73. Netherlands Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 74. Netherlands Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 75. Netherlands Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 76. Spain Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 77. Spain Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 78. Spain Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 79. Spain Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 80. Spain Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 81. Spain Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 82. Turkey Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 83. Turkey Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 84. Turkey Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 85. Turkey Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 86. Turkey Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 87. Turkey Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 88. Poland Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 89. Poland Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 90. Poland Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 91. Poland Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 92. Poland Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 93. Poland Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 94. South America Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 95. South America Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 96. South America Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 97. South America Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 98. South America Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 99. South America Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 100. South America Continuous Glucose Monitoring Market Share (%), By Country, 2017-2031F
Figure 101. Brazil Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 102. Brazil Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 103. Brazil Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 104. Brazil Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 105. Brazil Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 106. Brazil Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 107. Argentina Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 108. Argentina Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 109. Argentina Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 110. Argentina Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 111. Argentina Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 112. Argentina Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 113. Asia-Pacific Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 114. Asia-Pacific Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 115. Asia-Pacific Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 116. Asia-Pacific Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 117. Asia-Pacific Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 118. Asia-Pacific Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 119. Asia-Pacific Continuous Glucose Monitoring Market Share (%), By Country, 2017-2031F
Figure 120. India Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 121. India Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 122. India Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 123. India Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 124. India Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 125. India Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 126. China Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 127. China Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 128. China Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 129. China Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 130. China Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 131. China Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 132. Japan Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 133. Japan Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 134. Japan Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 135. Japan Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 136. Japan Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 137. Japan Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 138. Australia Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 139. Australia Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 140. Australia Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 141. Australia Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 142. Australia Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 143. Australia Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 144. Vietnam Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 145. Vietnam Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 146. Vietnam Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 147. Vietnam Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 148. Vietnam Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 149. Vietnam Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 150. South Korea Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 151. South Korea Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 152. South Korea Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 153. South Korea Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 154. South Korea Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 155. South Korea Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 156. Indonesia Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 157. Indonesia Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 158. Indonesia Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 159. Indonesia Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 160. Indonesia Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 161. Indonesia Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 162. Philippines Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 163. Philippines Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 164. Philippines Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 165. Philippines Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 166. Philippines Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 167. Philippines Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 168. Middle East & Africa Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 169. Middle East & Africa Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 170. Middle East & Africa Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 171. Middle East & Africa Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 172. Middle East & Africa Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 173. Middle East & Africa Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 174. Middle East & Africa Continuous Glucose Monitoring Market Share (%), By Country, 2017-2031F
Figure 175. Saudi Arabia Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 176. Saudi Arabia Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 177. Saudi Arabia Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 178. Saudi Arabia Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 179. Saudi Arabia Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 180. Saudi Arabia Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 181. UAE Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 182. UAE Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 183. UAE Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 184. UAE Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 185. UAE Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 186. UAE Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 187. South Africa Continuous Glucose Monitoring Market, By Value, In USD Billion, 2017-2031F
Figure 188. South Africa Continuous Glucose Monitoring Market, By Volume, In Thousand Units, 2017-2031F
Figure 189. South Africa Continuous Glucose Monitoring Market Share (%), By Component, 2017-2031F
Figure 190. South Africa Continuous Glucose Monitoring Market Share (%), By Age Group, 2017-2031F
Figure 191. South Africa Continuous Glucose Monitoring Market Share (%), By Diabetes Type, 2017-2031F
Figure 192. South Africa Continuous Glucose Monitoring Market Share (%), By End-user, 2017-2031F
Figure 193. By Component Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 194. By Age Group Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 195. By Diabetes Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX11675

Global continuous glucose monitoring market is projected to witness a CAGR of 11.13% during the forecast period 2024-2031, growing from USD 5.75 in 2023 to USD 13.38 in 2031. The continuous glucose monitoring market is an integral part of the medical device industry, accounting for one of the fastest growth rates. Factors are driving the market such as the increasing prevalence of diabetes, the growing adoption of CGM devices, increasing awareness about diabetes monitoring, and technological advancements.

Continuous glucose monitoring devices use glucose level measurements to manage diabetes by minimizing fingerstick tests. Continuous glucose levels are measured throughout the day by a sensor located on or beneath the patient's skin. A transmitter can be used together with some wearable appliance, for instance, a smartwatch, to display changes in blood sugar levels at any given moment of time. Nevertheless, it takes a while to adjust to using a CGM for diabetes management, although it simplifies the process. When CGM data is being utilized, the time-in-range method measures the duration patients have been within the desired glucose levels in addition to a number of times that their glucose has risen above (hyperglycemia) or gone below normal levels (hypoglycemia). A blood glucose meter provides a single-point estimate of a person's blood sugar level, while a CGM device offers a broader perspective on patterns in relation to glucose. It has been demonstrated in several studies that CGM devices help users keep their glucose levels at a constant range, eliminate low and high glucose levels cases, and reduce the chances of coming up with problems that are related to diabetes. Nevertheless, using CGM is a long-term solution.

In March 2024, Roche presented new continuous glucose monitoring technology with artificial intelligence at a conference on Advanced Technologies & Treatments for Diabetes in Italy. The company revealed its Accu-Chek SmartGuide. The device is under research and has not yet been approved for retail sales. There are several characteristics that Abbott and Dexcom CGMs and the Accu-Chek SmartGuide have in common. It has waterproof qualities, a one-step application technique, and a 14-day wear time. On the other hand, unlike some of the newest generation of devices, this CGM needs initial calibration.

Increasing Prevalence of Diabetes Globally

The demand for CGM has increased significantly along with the number of individuals with diabetes. 31% of the 23 million Americans who have diabetes receive insulin treatment, which enables them to use continuous glucose monitoring (CGM). The American Diabetes Association recommends CGM as the gold standard of treatment for those with type 1 diabetes and a crucial device for patients with type 2 diabetes undergoing insulin therapy. In conclusion, the increasing number of people with diabetes is driving demand for continuous glucose monitoring devices, which may significantly improve glucose control and health outcomes for those with the disease. With the increasing number of diabetic people, access to this technology is becoming a priority.

Technological Advancements to Increase Market Demand

The field of CGM technology is continually evolving, with numerous research projects and clinical trials underway. Diabetes is a significant healthcare challenge, and the potential for improving patient outcomes through CGM technology remains effective. Artificial intelligence and machine learning are expected to significantly evolve the role of CGM technology. These advancements will make artificial pancreas systems more precise and sensitive, allowing patients to live their lives naturally without being controlled by their diabetes. Dexcom introduced Dexco ONE+, a real-time continuous glucose monitoring device in Poland, Spain, and Belgium, in February 2024. On February 12th, the business introduced its CGM device in the Netherlands. In the upcoming months, Dexcom plans to introduce Dexcom ONE+ in the Middle East and Africa and other European nations. The Dexcom ONE+ system is made up of a transmitter that transmits CGM data, a water-resistant blood glucose sensor, and an application that works with smartphones to access the Dexcom One app.

Sensors Dominate the Component Segment in the Global Continuous Monitoring Market

Based on components, the sensors account for the highest share in the continuous glucose monitoring market. CGM sensors calculate the glucose level in the fluids between cells, and it is quite comparable to the glucose levels in the blood. Depending on the type of sensor a patient has, it may be necessary to change it every few weeks or at other specified intervals. Depending on the model, disposable CGM sensors need to be changed every 7 to 14 days. A few implanted sensors have a 180-day lifespan. Abbott introduced two over-the-counter glucose monitors in the United States in June 2024, competing against Dexcom's Stelo. Abbott had planned to launch Lingo in the United States after its release in the United Kingdom last year. The device analyzes glucose levels over the course of 14 days and can be worn on the upper arm to assist users in better understanding how their bodies respond to various diets, physical activities, and stresses. Abbott was given FDA approval on May 29th, 2024, to market its Lingo system without a prescription.

Home Care Settings Will Hold the Highest Share in the Forecast Period

In the future, home care settings are expected to witness a significant increase in demand for continuous glucose monitoring (CGM) devices. As the technology develops, with longer sensor wear times, more accuracy, and easier smartphone connection, CGM will become a more alluring alternative for home-based diabetes care. Compared to traditional self-monitoring, continuous glucose monitoring (CGM) is more convenient and is likely to increase adherence since it eliminates the need for fingerstick tests. By enabling patients to actively control their disease and prevent complications, more widespread utilization of CGM has the potential to revolutionize the way diabetes is treated. The use of these devices in homes is expected to increase in the upcoming years as they become more widely available and affordable.

Key Players Landscape and Outlook

Several medical device companies are flourishing in the continuous glucose monitoring market by planning and adopting new strategies. They are complying with new strategic initiatives for medical devices to increase their market presence. New agreements, contracts, acquisitions, mergers, investments, and partnerships are major ways through which they are trying to achieve higher market share.

In May 2024, Sensonics, a globally renowned manufacturer of implantable CGM systems, announced its partnership with Rimidi. The main aim of this collaboration is to formulate the Eversense Remote Patient Monitoring (RPM) Program, which will combine healthcare workflows easily. The Eversense CGM + RPM solution will integrate Rimidi's clinical management platform with Senseonic's durable Eversense sensor.

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Continuous Glucose Monitoring Market Outlook, 2017-2031F

4.1. Market Size & Forecast
- 4.1.1. By Value
- 4.1.2. By Volume
4.2. By Component
- 4.2.1. Transmitters
- 4.2.2. Receivers
- 4.2.3. Sensors
4.3. By Age Group
- 4.3.1. Children
- 4.3.2. Adults
- 4.3.3. Geriatric
4.4. By Diabetes Type
- 4.4.1. Type-1 Diabetes
- 4.4.2. Type-2 Diabetes
4.5. By End-user
- 4.5.1. Hospitals
- 4.5.2. Home Care Settings
- 4.5.3. ICU
- 4.5.4. Others
4.6. By Region
- 4.6.1. North America
- 4.6.2. Europe
- 4.6.3. Asia-Pacific
- 4.6.4. South America
- 4.6.5. Middle East and Africa
4.7. By Company Market Share (%), 2023

5. Global Continuous Glucose Monitoring Market Outlook, By Region, 2017-2031F

5.1. North America*
- 5.1.1. Market Size & Forecast
  - 5.1.1.1. By Value
  - 5.1.1.2. By Volume
- 5.1.2. By Component
  - 5.1.2.1. Transmitters
  - 5.1.2.2. Receivers
  - 5.1.2.3. Sensors
- 5.1.3. By Age Group
  - 5.1.3.1. Children
  - 5.1.3.2. Adults
  - 5.1.3.3. Geriatric
- 5.1.4. By Diabetes Type
  - 5.1.4.1. Type-1 Diabetes
  - 5.1.4.2. Type-2 Diabetes
- 5.1.5. By End-user
  - 5.1.5.1. Hospitals
  - 5.1.5.2. Home Care Settings
  - 5.1.5.3. ICU
  - 5.1.5.4. Others
- 5.1.6. United States*
  - 5.1.6.1. Market Size & Forecast
    - 5.1.6.1.1. By Value
    - 5.1.6.1.2. By Volume
  - 5.1.6.2. By Component
    - 5.1.6.2.1. Transmitters
    - 5.1.6.2.2. Receivers
    - 5.1.6.2.3. Sensors
  - 5.1.6.3. By Age Group
    - 5.1.6.3.1. Children
    - 5.1.6.3.2. Adults
    - 5.1.6.3.3. Geriatric
  - 5.1.6.4. By Diabetes Type
    - 5.1.6.4.1. Type-1 Diabetes
    - 5.1.6.4.2. Type-2 Diabetes
  - 5.1.6.5. By End-user
    - 5.1.6.5.1. Hospitals
    - 5.1.6.5.2. Home Care Settings
    - 5.1.6.5.3. ICU
    - 5.1.6.5.4. Others
- 5.1.7. Canada
- 5.1.8. Mexico

All segments will be provided for all regions and countries covered

5.2. Europe
- 5.2.1. Germany
- 5.2.2. France
- 5.2.3. Italy
- 5.2.4. United Kingdom
- 5.2.5. Russia
- 5.2.6. Netherlands
- 5.2.7. Spain
- 5.2.8. Turkey
- 5.2.9. Poland
5.3. Asia-Pacific
- 5.3.1. India
- 5.3.2. China
- 5.3.3. Japan
- 5.3.4. Australia
- 5.3.5. Vietnam
- 5.3.6. South Korea
- 5.3.7. Indonesia
- 5.3.8. Philippines
5.4. South America
- 5.4.1. Brazil
- 5.4.2. Argentina
5.5. Middle East and Africa
- 5.5.1. Saudi Arabia
- 5.5.2. UAE
- 5.5.3. South Africa

6. Market Mapping, 2023

6.1. By Component
6.2. By Age Group
6.3. By Diabetes Type
6.4. By End-user
6.5. By Region

7. Macro Environment and Industry Structure

7.1. Demand Supply Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
- 7.4.1. Political Factors
- 7.4.2. Economic System
- 7.4.3. Social Implications
- 7.4.4. Technological Advancements
- 7.4.5. Environmental Impacts
- 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter's Five Forces Analysis
- 7.5.1. Supplier Power
- 7.5.2. Buyer Power
- 7.5.3. Substitution Threat
- 7.5.4. Threat From New Entrant
- 7.5.5. Competitive Rivalry

8. Market Dynamics

8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies

10. Key Players Landscape

10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

13.1. Abbott Laboratories
- 13.1.1. Company Details
- 13.1.2. Key Management Personnel
- 13.1.3. Products and Services
- 13.1.4. Financials (As Reported)
- 13.1.5. Key Market Focus and Geographical Presence
- 13.1.6. Recent Developments
13.2. Medtronic Plc
13.3. Ypsomed AG
13.4. Senseonics Holdings Inc.
13.5. Insulet Corporation
13.6. Medtrum Technologies
13.7. Nemaura Medical Inc
13.8. Menarini Diagnostics S.A
13.9. Dexcom Inc
13.10. F.Hoffman-La Roche Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

持続血糖モニタリングの世界市場の評価：コンポーネント別、年齢層別、糖尿病タイプ別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Continuous Glucose Monitoring Market Assessment, By Component, By Age Group, By Diabetes Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の持続血糖モニタリング市場の見通し、2017年～2031年

第5章世界の持続血糖モニタリング市場の見通し（地域別、2017年～2031年）

第6章市場マッピング、2023年

第7章マクロ環境と産業構造

第8章市場力学

第9章規制枠組みとイノベーション

第10章主要参入企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要参入企業の見通し

第14章戦略的提言

第15章お問い合わせと免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Continuous Glucose Monitoring Market Outlook, 2017-2031F

5. Global Continuous Glucose Monitoring Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us and Disclaimer

持続血糖モニタリングの世界市場の評価：コンポーネント別、年齢層別、糖尿病タイプ別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Continuous Glucose Monitoring Market Assessment, By Component, By Age Group, By Diabetes Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の持続血糖モニタリング市場の見通し、2017年～2031年

第5章 世界の持続血糖モニタリング市場の見通し（地域別、2017年～2031年）

第6章 市場マッピング、2023年

第7章 マクロ環境と産業構造

第8章 市場力学

第9章 規制枠組みとイノベーション

第10章 主要参入企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要参入企業の見通し

第14章 戦略的提言

第15章 お問い合わせと免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Continuous Glucose Monitoring Market Outlook, 2017-2031F

5. Global Continuous Glucose Monitoring Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us and Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の持続血糖モニタリング市場の見通し、2017年～2031年

第5章世界の持続血糖モニタリング市場の見通し（地域別、2017年～2031年）

第6章市場マッピング、2023年

第7章マクロ環境と産業構造

第8章市場力学

第9章規制枠組みとイノベーション

第10章主要参入企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要参入企業の見通し

第14章戦略的提言

第15章お問い合わせと免責事項